Maybe you are interested...
Kerato Dermatological Lotion 200ml
Moisturizing lotion, developed to deeply moisturize dry and desquamated skin.
Thanks to the high concentration of urea and keratolytic and keratoplastic actives such as gluconolactone, it produces an intense action that, combined with the Kerato shampoo, allows the skin to remain free of desquamation and hydrated for a longer time.
How to use: Apply without diluting. Spray at about 20 cm of localized or generalized seborrheic lesion, performing a light massage to facilitate product penetration.
Presentation: 200ml
EAN: 8431166110043
Credit card
Pay your order securely with major credit cards: VISA, VISA Electron, 4B, or Mastercard.
You offers on a credit card discharged in your bank to operate in safe Internet shops.
COD
You will receive your order on the shipping address you have chosen and you will be cashed to give it to you.
Bizum
Securely pay your orders by indicating your mobile number and Bizum password.
Income / Wire Transfer
Your order will be shipped when we receive the payment or transfer of the amount.
The unpaid order will be automatically deleted in 5 days.
- Entity: Banco Sabadell
- Account: ES8000810165500002791882
Cash payment
You can make your payment in store to pick up your order.
(*) To pay with PayPal, Contrareembolso and Income/Bank Transfer minimum order will be 49€.
LETIPharma is a bio-pharmaceutical research company, independent and family capital.
In its different areas of expertise, seeks to provide society with products that add value to health care.
Its headquarters are in Barcelona and the industrial plant and the allergy research laboratory are in Tres Cantos (Madrid). It has subsidiaries in Germany (Ismaning and Witten) and in Portugal (Oporto). LETIPharma operates with exclusive distributors in various countries in Europe, Latin America and Africa.
Research and specialization are critical elements in the strategy of LETIPharma. Having innovative and patented products is essential to grow internationally in the chosen market segments. Therefore, LETIPharma has been devoting to research and product development between 10 and 20 percent of its turnover.
Internationalization is an essential element of our strategy. For a specialized company, penetrating foreign markets is a requirement to be able to grow, and this is facilitated by having our own products derived from research. Thus, for LETIPharma, internationalization is both a necessity and an opportunity, as well as being an important enriching element for your organization.
LETIPharma maintains a strategy of close and lasting collaborations with companies in the sector to boost its penetration in foreign markets and to expand its range of products. Also, with universities and research centers, for research and development projects, inside and outside of Spain.
LETIPharma is a founding member of Asebio (Spanish Association of Biocompanies) and of the EAMG (European Allergens Manufacturers Group), is a partner of Farmaindustria, of FENIN (Spanish Federation of Health Technology Companies) and of BPI (Bundesverband der Pharmazeutischen Industrie) and contributes to various organizations and non-profit foundations in areas related to health and education.
Leave us a message 